Healthcare
IHH Singapore goes preventive with new Healthspan programme
IHH Singapore goes preventive with new Healthspan programme
It estimates biological age relative to a person’s chronological age by blood analysis.
25 minutes ago
South Korea, Mongolia strike fresh deal on health cooperation
They will cooperate on healthcare delivery systems, among other areas.
1 hour ago
Abu Dhabi to launch Rare Diseases Centre of Excellence
It will serve as a flagship hub for diagnosis, amongst others.
3 days ago
Sustainability push lifts medical device reprocessing to $3.8b
Asia-Pacific is projected to be the fastest-growing region.
3 days ago
HMG, OncoCare ink Pan-Asian deal to fast-track cancer care access
This includes early screening, amongst others.
3 days ago
Health ministry unveils homegrown AI model built for patients
It aims to address healthcare AI issues, which is mostly trained on the Western population.
3 days ago
Australia funds $10.4m RNA lung therapy trials at Monash
Researchers aim for the drug to slow functional decline.
4 days ago
AI in pharma market to hit $28.6b by 2034 on drug discovery push
Asia Pacific is set to post the fastest growth.
4 days ago
Gene editing market may nearly triple to $30.5b by 2033
Asia Pacific is seen as fastest-growing region.
4 days ago
Biologics boom pushes biopharma equipment market toward $116.4b
Asia-Pacific is emerging as the fastest-growing region.
4 days ago
Ageing, chronic diseases push APAC medtech towards $132b by 2030
Despite this, few companies in the region have scaled globally.
5 days ago
India rolls out terminology, drug registry
The terminology service will be set up for consistent interpretation and exchange of health data.
6 days ago
AI-powered microscopy software poised for $3.09b surge by 2031
North America accounted for the largest market share in 2025.
6 days ago
China’s healthcare defies Hang Seng slump with 0.9% gain
Investor sentiment, however, weakened during the second quarter.
6 days ago
Abu Dhabi and MIT Koch advance AI-driven cancer research
It includes physician-scientist fellowships.
Biomarkers market to top $112b by 2031 on drug discovery demand
Consumables held the largest share at 73.4% in 2025.
AU’s Royal North Shore expands cancer trials access with new unit
It was funded by a $13.8m (AU$20m) gift.
Most Read
1. Boustead buys 60% of UroMedTech in $6m prostate cancer bet 2. Health ministry unveils homegrown AI model built for patients 3. China’s healthcare defies Hang Seng slump with 0.9% gain 4. India rolls out terminology, drug registry 5. DNA diagnostics market to reach $24.7b by 2034 on precision medicine, genomic advancementsResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential